Browse by Featured categories
Aging
Children, Families & Pregnancy
Dental
Online
Alcohol, Tobacco, and Substance Use
Alzheimer’s Disease & Dementia
Asthma,Lungs & Allergies
Bones, Muscles and Joints
Brain, Spine & Nervous System
Covid-19 & Infectious Disease
Diabetes, Heart and Blood Vessels
Digestive System (GI), Bowel & Liver
Health Mental, Behavioral Health & Developmental Conditions
Healthy Volunteer
Cancer
Diet, Nutrition, Exercise, & Sleep
Browse by Featured categories
Aging
Children, Families & Pregnancy
Dental
Online
Alcohol, Tobacco, or Other Substance Use
Alzheimer’s Disease & Dementia
Asthma,Lungs & Allergies
Bones, Muscles and Joints
Brain, Spine & Nervous System
Covid-19 & Infectious Disease
Diabetes, Heart and Blood Vessels
Digestive System (GI), Bowel & Liver
Health Mental, Behavioral Health & Developmental Conditions
Healthy Volunteer
Cancer
Diet, Nutrition, Exercise, & Sleep
Browse by Featured categories
Aging
Alcohol, Tobacco and Substance Use
Brain, Spine and Nerves
Cancer
Diabetes
Diet, Exercise and Nutrition
Healthy Volunteers
Mental and Behavioral Health
Alzheimer’s Disease and Dementia
Autoimmune Disease
Bladder and Kidneys
Bones, Muscles and Joints
Community and Environmental Health
Dental
Eye Conditions
Genetic and Rare Conditions
GI, Liver and Pancreas
Hearing, Speech and Language
Heart Health
Infectious Disease
Lungs, Asthma and Allergies
Maternal, Infant and Child Health
Online Studies
Public Health Studies
Skin and Wounds
Sleep
Surgery, Transplant and Imaging
Thyroid, Hormones and Metabolism
Help Shape the Future of Health
with the Indiana Biobank
By donating a small blood sample, you can help researchers discover better treatments and improve health across Indiana.
Who Can Join?
All IU Health Patients of Any Age
What Is Involved?
It's easy-we collect a blood sample during your regular doctor visit.
Why does it Matter?
By taking part, you're helping improve care for you, your loved ones, and people across Indiana.
Recently added/updated trials
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib
A
Ajay Gupta
The purpose of the study is to provide efficacy, safety and tolerability data for remibrutinib to support regulatory approval worldwide as a treatment for relapsing multiple sclerosis (RMS). Two identical Phase III trials (CLOU064C12301 and CLOU064C12302) will be conducted simultaneously.THIS STUDY IS ENROLLING BY INVITATION ONLY
A Phase III Multicenter Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Adult Patients With Relapsing Multiple Sclerosis
A
Ajay Gupta
A study to evaluate the efficacy and safety of fenebrutinib on disability progression and relapse rate in adult participants with RMS. Eligible participants will be randomized 1:1 to either fenebrutinib or teriflunomide. Open-Label Extension (OLE) phase is contingent on a positive benefit-risk result in the Primary Analysis of the study.THIS STUDY IS ENROLLING BY INVITATION ONLY
FIT Core - Musculoskeletal Function Imaging and Testing (MSK-FIT) Resource Core
S
Stuart Warden
S
Sharon Moe, MD
We are looking for people of all ages, regardless of health condition, to take part in a study that is looking for new treatments for bone and muscle disorders.Bone and muscle disorders are the leading cause of disabilty in the United States. Researchers want to find out more about how people are affected by aging, injury, disease and illness. Your participation will help advance the diagnosis and treatment of bone and muscle disorders.
Stronger Hearts, Healthier Lives: Join Our Study
N
Navin Kaushal
Why is this study being done?Cardiokidney Metabolic Syndrome or CKM is a new syndrome recognized by the American Heart Association and occurs when an individual has a combination of conditions which includes being overweight, in addition to having metabolic risk factors (hypertriglyceridemia [≥135 mg/dL], hypertension, metabolic syndrome, diabetes), or chronic kidney disease. Researchers at Indiana University are conducting a study to learn more about how to promote exercise among individuals with CKM. CKM may have the potential to be reversed by participating in regular exercise. Findings from this study will help us understand physical activity levels among individuals with CKM, with the goal of designing an effective exercise program for those individuals. Who can take part?Adults (ages 18 and older) who are at risk of developing Cardiokidney Metabolic Syndrome (CKM).
Indiana Biobank – Help Shape the Future of Medicine with the Indiana Biobank!
T
Tatiana Foroud
The Indiana Biobank is a research study started in 2010 by Indiana University School of Medicine and IU Health. The Indiana Biobank is like a giant library—but instead of books, it holds over 60,000 blood and other samples. Each sample is connected to the person’s medical records. The person’s name and personal details are removed before researchers can use the samples. These samples help doctors and scientists discover better ways to treat and prevent diseases!When you donate a small blood sample, you’re helping researchers learn more about how to keep people healthy. Your sample is unique, and it can help make sure future treatments work for everyone.Watch this video to learn more:
Exploring Treatment Options After Lung Cancer Surgery
V
Vijaya L. Kakani, MD
Do you have non-small cell lung cancer (NSCLC) but the cancer was not fully removed by surgery? You may qualify for a study exploring treatment options for NSCLC.This research study is testing whether adding a medication called sacituzumab tirumotecan to pembrolizumab after surgery may help prevent non-small cell lung cancer (NSCLC) from returning in people whose cancer was not completely removed by surgery. You may be able to take part if you:Are an adult diagnosed with non-small cell lung cancer (NSCLC)Have had surgery for NSCLCDid not have a complete response after surgeryAre eligible to receive pembrolizumab
Walking Juntos: Developing and Testing a Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
S
Sandeep Batra, MD
This clinical trial tests the impact of a culturally-tailored home-based physical activity program on physical fitness in Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After treatment for cancer, some AYA survivors experience long-term effects from the cancer and its treatment including weight gain, fatigue and decreased physical fitness. Hispanic or Latino/Latina survivors may have a higher risk of these effects compared to non-Hispanics. Regular physical activity helps maintain healthy weight, energy levels and overall health. Participating in a culturally-tailored home-based physical activity program may help increase physical activity in Hispanic or Latino/Latina AYA childhood cancer survivors.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic. Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:IU Clinical Trials Office Email: iutrials@iu.edu Phone: (317) 278-5632
